Huang, C., Huang, Y., & Hsu, B. R. (2018). A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin. Ann Saudi Med.
Citação norma ChicagoHuang, Chung-Huei, Yu-Yao Huang, and Brend Ray-Sea Hsu. "A Short-term Follow-up of Glycemic and Body Weight Changes in Diabetic Patients Who Replaced Dipeptidyl Peptidase-4 Inhibitors With the Sodium-glucose Cotransporter 2 Inhibitor Empagliflozin." Ann Saudi Med 2018.
MLA CitationHuang, Chung-Huei, Yu-Yao Huang, and Brend Ray-Sea Hsu. "A Short-term Follow-up of Glycemic and Body Weight Changes in Diabetic Patients Who Replaced Dipeptidyl Peptidase-4 Inhibitors With the Sodium-glucose Cotransporter 2 Inhibitor Empagliflozin." Ann Saudi Med 2018.